With a background in engineering and science, Janet Freeman-Daily has used social media to educate and unite patients to help advance research on a rare genomic mutation in lung cancer. Freeman-Daily, who was diagnosed with advanced non-small cell lung cancer in 2011, never smoked. “The more we’ve learned about the genomic drivers of cancer, the more we’ve discovered that any patient can have a genomic driver. It doesn’t matter whether we smoked or not, so why are we blaming people for having lung cancer?”
Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
Financial Screenings for People with CancerCancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
Aggressive Approach to Very Advanced Cancer Does Not Extend SurvivalStudy shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Alexis Browning
